Lybalvi Approved for Schizophrenia, Bipolar I Disorder
The approval was based on data from 27 clinical studies, including the phase 3 ENLIGHTEN-1 and ENLIGHTEN-2 studies.
Bipolar Disorders
Lumateperone Under Review for Bipolar Depression
The sNDA submissions are supported by data from 2 global randomized, double-blind, placebo-controlled phase 3 studies.
Panel of 26 Biomarkers May Allow for Precision Medicine Treatment Plans Among Patients With Mood Disorders
This study looked at whether biomarkers can aid in the diagnosis of mood disorders as self-reporting or the clinical impression of a health care professional are not always reliable.
History of Depression, Anxiety Inversely Correlates With Age of Onset in Alzheimer Disease
There may be an association between a history of psychiatric disorders in patients and age of onset of Alzheimer disease.
Dementia Diagnoses Higher Among Older US Adults with Schizophrenia
The researchers sought to estimate the age-specific incidence and prevalence of dementia diagnoses among older adults with schizophrenia in the United States compared to those without serious mental illness.
Patients With Mood Disorders at Increased Risk for Diagnosis of Attention Deficit Hyperactivity Disorder Throughout Life
Researchers from Dalhousie University in Canada searched publication databases through September of 2020 for articles on ADHD, attention deficit disorder, bipolar disorder, and affective psychosis.
Lumateperone sNDAs Submitted for Bipolar Depression Indication
The sNDA submissions are supported by data from 2 global randomized, double-blind, placebo-controlled phase 3 studies.
LEF1 Gene a Possible Target for Bipolar Disorder Drug Development
While treatment for mood stabilization in bipolar disorder is most commonly lithium, all patients do not respond to such treatment. The authors of this study investigated what causes lithium resistance.
Psychotropic Drug Indications
A comparative list of psychotropic medications with their mood disorder indications (bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others).
Patients With Both Dementia and Severe Mental Illness Experience Faster Cognitive Decline
Researchers analyzed data from the population of 4 South London boroughs to determine the impact of comorbid bipolar disorder and schizophrenia on the cognitive decline in dementia.
- Loading...
Loading...
Next post in Bipolar Disorder
Loading... 
Loading...